| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $18.9M | +290.5% |
| SG&A Expense | $5.4M | +2.0% |
| Operating Income | -$24.3M | -140.6% |
| Pre-tax Income | -$24.3M | -185.6% |
| Income Tax | $21K | +150.9% |
| Net Income | -$24.3M | -185.6% |
| EPS (Basic) | -$1.25 | -115.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.5M | -37.6% |
| Total Assets | $18.9M | -39.7% |
| Current Liabilities | $6.0M | +157.6% |
| Total Liabilities | $6.6M | +143.1% |
| Stockholders' Equity | $12.3M | -57.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.0M | -77.7% |
| Financing Cash Flow | $7.8M | -75.3% |